Navigation Links
Volcano Reports 22 Percent Increase in Third Quarter Revenues
Date:11/5/2009

== Liabilities and Stockholders' Equity Current liabilities: Accounts payable $15,532 $14,867 Accrued compensation 12,841 12,690 Accrued expenses and other current liabilities 9,737 10,745 Deferred revenues 4,913 4,833 Short-term debt - 151 Current maturities of long-term debt 40 57 -- -- Total current liabilities 43,063 43,343 Long-term debt 9 34 Deferred revenues 2,028 1,914 Other 1,110 456 ----- --- Total liabilities 46,210 45,747 Stockholders' equity 224,383 229,732 ------- ------- $270,593 $275,479 ======== ======== VOLCANO CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data) (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, ------------- ----------------- 2009 2008 2009 2008 ---- ---- ---- ---- Revenues
'/>"/>
SOURCE Volcano Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Volcano Corporation Announces Proposed Public Offering of Common Stock
2. Volcano Corporation Reports Preliminary Third Quarter 2007 Revenues
3. Volcano Reports Record Third Quarter Revenues
4. Volcano Corporation Presentation at Piper Jaffray Conference to be Webcast
5. Volcano Corporation Selects Xactly to Drive Strategic Sales Performance Management
6. Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent
7. Chilean volcano captured blasting ash
8. Volcano Corporation Presentation at JMP Conference to be Webcast
9. Volcano Presentation at Canaccord Adams Conference to be Webcast
10. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
11. Volcano Reports 40 Percent Growth in Quarterly Revenues

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...sts offer advice on the topic of most concern to M...mpletely and finally; forsake utterly; to desert. ...s) November 24, 2009 -- Dr. Suzanne LaCombe and Dr...is its groundbreaking "The New Paradigm for 2... ( http://www.myshrink.com )., , ,Titled "Aba...
(Date:11/24/2009)...hes EyeCentral Remote Video Platform for the Secur... for Central Stations and Security Dealers. , ...r 24, 2009 -- NCL Security Launches EyeCentral Rem...nerate Recurring Monthly Revenue for Central Stati...urity systems has been and still is a great trend ...
(Date:11/23/2009)...n determined that only 663,000 of the approximatel...V) infection received antiviral therapy between 20...ng, in part because only half of the patients know...inues, by 2030 less than 15% of liver-related deat.... This study, the first to analyze nationwide pra...
(Date:11/23/2009)...gh cost of drug advertising that does little to bo...rsity of British Columbia health policy researcher... of Internal Medicine , examined the US sales patt... by the trade name Plavix used to prevent blood cl...ected to study the impact of advertising on sales ...
(Date:11/23/2009)...the problem, researchers say , , MONDAY,...ir anger over unfair treatment at work could be hu... , Men who consistently failed to express their... supervisor were more than twice as likely to have...ho vented their anger, claims a report in the Nov....
Breaking Medicine News(10 mins):Health News:Home For the Holidays: MyShrink.com Announces the Second in its Successful Six-Part Webinar Series: "Abandonment: The Hidden Fear" 2Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3
...ions seen on MRIs with limited side effects, study...) -- One of the first pills to treat the "relapse-...wn to help fight the disease with few side effects... large, this doesn,t look as strong as the stronge...
...rigo Company,(Nasdaq: PRGO ; TASE) today announce.... Food and Drug Administration to manufacture and ...mg/mL. The product is comparable,to McNeil Consume...Joseph C. Papa stated, "This approval,reflects bot...
...ir shows no added benefit , , THURSDAY, Ju...r (Zovirax) doesn,t reduce the risk of HIV-1 infec... genital herpes, a U.S. study finds. , Previous re...on by two- to threefold. , In this new, randomized...
...x Competitive Bidding System for DMEPOS,Equipment,..., chair of the House Ways & Means Health Subcommit...MEPOS Competitive Acquisition Reform,Act of 2008. ...ill. In response, Bruce T. Roberts, RPh, executive...
...ternational clinical trial coordinated by the Mont...ew England Journal of Medicine . The Atrial Fibril... was a prospective, multicentre project involving ... (a very common heart rhythm disorder) further inc...
...19 /Xinhua-PRNewswire-FirstCall/ -- Benda,Pharmace...ased,pharmaceutical company producing both Gendici...the treatment of cancer, and traditional Chinese a...008. Mr. Mo joined the Board in 2007 and served as...
Other Medicine News:Health News:Experimental Drug Fights Multiple Sclerosis Activity 2Health News:Experimental Drug Fights Multiple Sclerosis Activity 3Health News:Perrigo Announces Approval for Rx Cetirizine Syrup 2Health News:Herpes Suppression May Not Prevent HIV Infection 2Health News:NCPA Statement Endorsing H.R. 6252 and S.3144 2Health News:The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation 2Health News:The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation 3Health News:Benda Pharmaceutical Announces Resignation of Board Member 2
(Date:11/23/2009)...PRNewswire/--Reportlinker.comannouncesthatanewmark...HolterMonitoringSystems-AGlobalMarketReview ,,...itoring-Systems---A-Global-Market-Review.html#utm_...gn=prnewswire ,, Cardiovascularmonitoringis...ientsneedtobecontinuouslymonitoredduringdiagnostic...
(Date:11/23/2009)...andNOIDA,India,Nov.23/PRNewswire-USNewswire/--Jubi...AB),andSouthernResearchInstitutetodayannouncedajoi...nnovationandenablingtechnologiesintheareasofOncolo...ueU.S.-Indiaarbitragedandleveragedpartnershipthatw...rpatientsworldwide.AMemorandumofUnderstandingwassi...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/-- CumberlandPharmace...-lineresultsfromastudyevaluatingthesafetyandeffica...nhospitalizedburnpatients. ,, Statisticalsignif...verinburnpatientsoverthefirst24hoursoftreatment.Th...ddegreeburnscoveringmorethan10percenttotalbodysurf...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Exercise May Prevent Prostate Cancer 3A Study 58366 1BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease 58361 1BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease 58361 2Comprehensive understanding of bacteria could lead to new insights into many organisms 10114 1Comprehensive understanding of bacteria could lead to new insights into many organisms 10114 2
Refraction System RT-2100
Ultramatic RX Master PHOROPTOR Refracting Instrument - Plus Cylinder Black
Maddox Rod, short handle (12cm)
Snellen 10' Eye Test Chart
Medicine Products: